Terms: = Cervical cancer AND WFDC2, EDDM4, HE4, WAP5, dJ461P17.6 AND Diagnosis
10 results:
1. Serum expression of tumor marker CA242 in patients with different gynecological diseases.
Zhu J; Li H
Lab Med; 2023 Nov; 54(6):613-617. PubMed ID: 37035887
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of he4 as a prognostic biomarker in uterine cervical cancer
Dubey H; Ranjan A; Durai J; Khan MA; Lakshmy R; Khurana S; Gupta S; Meena J; Ray MD; Tanwar P; Chopra A; Tiwari S
Cancer Treat Res Commun; 2023; 34():100672. PubMed ID: 36525756
[TBL] [Abstract] [Full Text] [Related]
3. Serum Human Epididymis Protein 4 as a Prognostic Marker in cervical cancer.
Hwang WY; Suh DH; Kim K; Kim YB; No JH
Cancer Control; 2022; 29():10732748221097778. PubMed ID: 35506739
[TBL] [Abstract] [Full Text] [Related]
4. Application Value of Real-Time Ultrasonic Elastograph with Serum Human Epididymis Protein 4, Interleukin-33, and Carbohydrate Antigen 153 in diagnosis of Early cervical cancer.
Guo M; Liang L; Wu L; Xie D; Li J
J Healthc Eng; 2022; 2022():4880874. PubMed ID: 35449844
[TBL] [Abstract] [Full Text] [Related]
5. Circulating tumor cells in gynaecological malignancies.
Kiss I; Kolostova K; Pawlak I; Bobek V
J BUON; 2020; 25(1):40-50. PubMed ID: 32277613
[TBL] [Abstract] [Full Text] [Related]
6. Tissue expression of human epididymal secretory protein 4 may be useful in the differential diagnosis of uterine cervical tumors.
Diniz G; Karadeniz T; Sayhan S; Akata T; Aydiner F; Ayaz D; Solakoglu Kahraman D; Akman T
Ginekol Pol; 2017; 88(2):51-55. PubMed ID: 28326512
[TBL] [Abstract] [Full Text] [Related]
7. Detection of circulating tumour cells may add value in endometrial cancer management.
Ni T; Sun X; Shan B; Wang J; Liu Y; Gu SL; Wang YD
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():1-4. PubMed ID: 27756035
[TBL] [Abstract] [Full Text] [Related]
8. [The utility of metalloproteinases (MMPs) and their inhibitors (TIMPs) in diagnostics of gynecological malignancies].
Mieszało K; Ławicki S; Szmitkowski M
Pol Merkur Lekarski; 2016 Mar; 40(237):193-7. PubMed ID: 27088204
[TBL] [Abstract] [Full Text] [Related]
9. The role of he4 in ovarian cancer follow-up: a review.
Piovano E; Attamante L; Macchi C; Cavallero C; Romagnolo C; Maggino T; Landoni F; Gadducci A; Sartori E; Gion M; Zola P
Int J Gynecol Cancer; 2014 Oct; 24(8):1359-65. PubMed ID: 25054447
[TBL] [Abstract] [Full Text] [Related]
10. he4 as a biomarker for ovarian and endometrial cancer management.
Li J; Dowdy S; Tipton T; Podratz K; Lu WG; Xie X; Jiang SW
Expert Rev Mol Diagn; 2009 Sep; 9(6):555-66. PubMed ID: 19732003
[TBL] [Abstract] [Full Text] [Related]
